- Home
- KRRO vs SSSS Comparison
KRRO vs SSSS Comparison
Compare KRRO & SSSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRRO
- SSSS
- Stock Information
- Founded
- KRRO 2014
- SSSS 2010
- Country
- KRRO United States
- SSSS United States
- Employees
- KRRO N/A
- SSSS N/A
- Industry
- KRRO Biotechnology: Pharmaceutical Preparations
- SSSS Finance: Consumer Services
- Sector
- KRRO Health Care
- SSSS Finance
- Exchange
- KRRO Nasdaq
- SSSS Nasdaq
- Market Cap
- KRRO 125.4M
- SSSS 138.2M
- IPO Year
- KRRO 2019
- SSSS N/A
- Fundamental
- Price
- KRRO $12.90
- SSSS $8.37
- Analyst Decision
- KRRO Strong Buy
- SSSS Strong Buy
- Analyst Count
- KRRO 7
- SSSS 3
- Target Price
- KRRO $85.67
- SSSS $9.33
- AVG Volume (30 Days)
- KRRO 99.7K
- SSSS 261.6K
- Earning Date
- KRRO 08-12-2025
- SSSS 08-06-2025
- Dividend Yield
- KRRO N/A
- SSSS 3.01%
- EPS Growth
- KRRO N/A
- SSSS N/A
- EPS
- KRRO N/A
- SSSS N/A
- Revenue
- KRRO $4,821,000.00
- SSSS $3,644,430.00
- Revenue This Year
- KRRO $65.08
- SSSS $5,400.03
- Revenue Next Year
- KRRO N/A
- SSSS N/A
- P/E Ratio
- KRRO N/A
- SSSS N/A
- Revenue Growth
- KRRO N/A
- SSSS N/A
- 52 Week Low
- KRRO $10.29
- SSSS $3.52
- 52 Week High
- KRRO $98.00
- SSSS $8.77
- Technical
- Relative Strength Index (RSI)
- KRRO 51.40
- SSSS 67.40
- Support Level
- KRRO $12.27
- SSSS $8.31
- Resistance Level
- KRRO $15.15
- SSSS $8.35
- Average True Range (ATR)
- KRRO 1.13
- SSSS 0.36
- MACD
- KRRO 0.25
- SSSS -0.02
- Stochastic Oscillator
- KRRO 57.01
- SSSS 73.42
About KRRO Korro Bio Inc.
Korro Bio Inc is a biopharmaceutical company with a mission to discover, develop, and commercialize a new class of genetic medicines based on editing RNA, enabling the treatment of both rare and highly prevalent diseases. It is generating a portfolio of differentiated programs that are designed to harness the body's natural RNA editing process to effect a precise yet transient single base edit. By editing RNA instead of DNA, Korro Bio is expanding the reach of genetic medicines by delivering additional precision and tunability.
About SSSS SuRo Capital Corp.
SuRo Capital Corp is a non-diversified closed-end management investment company. The company's investment objective is to maximize its portfolio's total return, principally by seeking capital gains on its equity and equity-related investments.